Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-14-087782
Filing Date
2014-12-19
Accepted
2014-12-19 10:15:50
Documents
1
Period of Report
2014-12-17

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 7832
  Complete submission text file 0001104659-14-087782.txt   9155
Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address 550 HILLS DRIVE BEDMINSTER NJ 07921 (908) 450-5300
NPS PHARMACEUTICALS INC (Issuer) CIK: 0000890465 (see all company filings)

EIN.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 550 HILLS DRIVE 3RD FLOOR BEDMINSTER NJ 07921
Business Address
Selisker Rachel R (Reporting) CIK: 0001313793 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23272 | Film No.: 141297852